C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
01/2010
01/07/2010	US20100004241 Non-imidazole aryloxyalkylamines
01/06/2010	EP2139872A1 Novel antibiotics
01/05/2010	US7642277 Non-nucleoside reverse transcriptase inhibitors
01/05/2010	CA2545999C 1,2-di(cyclic)substituted benzene compounds
01/05/2010	CA2318192C .beta.2-adrenergic receptor agonists
12/2009
12/31/2009	US20090326220 Tetrazole-Substituted Arylamides as P2X3 and P2X2/3 Antagonists
12/31/2009	US20090324540 Compounds and compositions for delivering active agents
12/30/2009	WO2009158561A1 Decontamination system
12/30/2009	EP2137208A2 Compounds for diagnosing apoptosis
12/30/2009	EP1608352B1 Polyamine compounds for treating chemokine receptor mediated diseases
12/29/2009	US7638587 low polydispersity
12/29/2009	US7638514 Agriculture
12/29/2009	CA2370250C Di-aryl acid derivatives as ppar receptor ligands
12/24/2009	US20090318681 Metal complex, and use thereof
12/24/2009	US20090318483 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist;
12/24/2009	US20090318481 Potentiators Of Glutamate Receptors
12/23/2009	EP1523475B1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
12/22/2009	US7635662 Useful in recording energy such as heat/pressure; storage stability; for heat-sensitive recording media on railroad tickets
12/17/2009	WO2009150248A1 Compounds which can be used for the treatment of cancers
12/17/2009	US20090312555 Process and intermediate compounds useful in the preparation of statins
12/17/2009	US20090312315 Pai-1 inhibitor
12/17/2009	CA2727296A1 Compounds which can be used for the treatment of cancers
12/16/2009	EP2132187A2 Dual-acting antihypertensive agents
12/16/2009	CN101605768A Chelating agent
12/15/2009	US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions
12/10/2009	WO2009148291A2 3- or 4-substituted piperidine compounds
12/10/2009	WO2009148290A2 3-substituted propanamine compounds
12/10/2009	US20090306397 Method for the production of substituted azoles
12/10/2009	US20090306112 Antiviral protease inhibitors
12/10/2009	US20090306078 Compounds that inhibit hif-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component
12/10/2009	US20090304797 Process for the Preparation of Micronized Valsartan
12/10/2009	CA2725742A1 3- or 4-substituted piperidine compounds
12/10/2009	CA2725740A1 3-substituted propanamine compounds
12/09/2009	EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/08/2009	US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
12/03/2009	WO2009145219A1 Therapeutic agent for alzheimer's disease
12/03/2009	WO2009103218A8 Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof
12/03/2009	US20090298899 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); {3-[(4-Chloro-biphenyl-3-carbonyl)-amino]-phenyl}-acetic acid; glaucoma or ocular hypertension; dysmenorrhoea, preterm labour, immune disorders, inflammatory disorders
12/03/2009	CA2729812A1 Therapeutic agent for alzheimer's disease
12/02/2009	EP1965805B1 Urea derivatives useful as calcium receptor modulators
12/02/2009	EP1646636B1 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
12/02/2009	CN101591304A Compound containing tetrazolyl groups and polymers thereof
12/02/2009	CN100564366C Derivatives of 1,3-diones having a herbicidal activity
12/01/2009	US7625926 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
12/01/2009	US7625892 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
11/2009
11/26/2009	US20090291993 Difluorophenol Derivatives and Their Use
11/25/2009	EP2121640A1 Novel semicarbazide and carbonylhydrazide derivatives useful as potassium channel modulators
11/25/2009	CN101585784A Method for purifying sartan side chain compound
11/25/2009	CN100562516C Beta-amyloid protein production/secretion inhibitors
11/24/2009	US7622464 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists
11/19/2009	US20090286990 Process for preparing irbesartan
11/19/2009	US20090286771 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
11/17/2009	CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009	CA2399299C Compounds with chelation affinity and selectivity for first transition series elements and their use
11/12/2009	US20090281326 Process For the Preparation of Angiotensin II Antagonist
11/12/2009	US20090281155 Dimeric Small Molecule Potentiators of Apoptosis
11/11/2009	EP2116548A1 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
11/11/2009	EP2116242A1 New pharmaceutical composition
11/11/2009	EP1937654B1 Process for obtaining valine derivatives useful for obtaining a pharmaceutically active compound
11/11/2009	EP1575964B1 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists
11/04/2009	EP1817296B1 Potentiators of glutamate receptors
11/03/2009	US7612206 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors
10/2009
10/29/2009	US20090270470 Compounds I
10/29/2009	US20090270421 Inhibitors of fatty acid amide hydrolase
10/29/2009	US20090270367 Substituted hydroxyethylamine aspartyl protease inhibitors
10/27/2009	US7608631 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars
10/27/2009	US7608618 1-(2,2,2-trifluoroethanoyl)pyrrolidine-2-carboxylic acid [4-methoxy-3-(3-pyrazin-2-yl-ureido)phenyl]-amide; 4-Methoxy-N-(3-methylamino-propyl)-3-(3-pyrazin-2-yl-ureido)-benzamide; checkpoint kinase Chk1 inhibitor; chemosensitizing agents useful in the treatment of diseases related to DNA damage
10/27/2009	US7608249 Magnetic resonance imaging of substrate molecule different from water; shortening relaxation times; in vivo mapping citrate; tumors
10/27/2009	CA2536870C Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists
10/22/2009	WO2009127715A1 Compounds comprising paramagnetic chelates arranged around a central core and their use in magneto resonance imaging and spectroscopy
10/21/2009	EP1608374B9 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/21/2009	CN101560218A Organometallic complex of nonlinear optical and ferroelectric material, synthesis and application thereof
10/21/2009	CN101560190A Method for researching and controlling impurity E in valsartan
10/20/2009	US7605163 Benzoyl-piperazine derivatives
10/20/2009	CA2376497C Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging
10/15/2009	WO2009125606A1 Pai-1 inhibitor
10/15/2009	WO2009124962A2 Sulfonamides
10/15/2009	WO2009124764A1 Compound composed of a metal ion and a marker precursor having two or more targeting vectors, and use of the compound
10/15/2009	WO2007017897A3 Novel crystalline forms of (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)bi-phenyl-4-ylmethyl]-amine
10/15/2009	US20090258918 EP4 receptor agonist, compositions and methods thereof
10/15/2009	CA2720530A1 Sulfonamides
10/15/2009	CA2720096A1 Pai-1 inhibitor
10/14/2009	CN101555212A Synthesized micromolecule compound capable of conveying bioactivator and application thereof
10/14/2009	CN100548993C Salts of valsartan
10/14/2009	CN100548123C 5-iodotetrazoles
10/13/2009	US7601730 Carboxylic acid derivatives, their preparation and use
10/13/2009	CA2419416C Tetrazolyl-phenyl acetamide glucokinase activators
10/08/2009	US20090252676 N-alkoxyamide conjugates as imaging agents
10/07/2009	CN101553224A Novel imidazothiazoles and imidazoxazoles
10/06/2009	US7598386 Sulphones which modulate the action of gamma-secretase
10/06/2009	CA2301377C N-aroylphenylalanine derivatives
10/01/2009	WO2009117888A1 Phosphodiesterase iii inhibitors, preparation methods and medical uses thereof
10/01/2009	WO2009065070A4 Prostaglandin e1 and e2 analogs for the treatment of various medical conditions
09/2009
09/30/2009	CN101547898A Transdermal delivery systems of beta-lactam antibiotics
09/30/2009	CN101544614A Phosphodiesterase III inhibitor, method for preparing same and medicinal application thereof
09/29/2009	US7595405 Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
09/29/2009	US7595345 side effect reduction; bone disease and psoriasis; compounds display the desirable cell differentiation and antiproliferative effects with reduced calcium mobilization; 2-(4-{1-Ethyl-1-[4-(1-hydroxy-cyclopentylethynyl)-3-methyl-phenyl]-propyl}-2-methyl-benzoylamino)-2-methyl-propionic acid
09/29/2009	US7595344 Sulphones which modulate the action of gamma secretase
09/29/2009	US7595343 Inhibitors of histone deacetylase
09/29/2009	US7595332 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity

1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 97